Wafra Inc.

SEC CIK: 0000920440
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Wafra Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overview All 13F holders of HALO Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2023

Holdings of HALO by Wafra Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−53,877−100.0%	Sold out	Holders
Q1 2024	53,877	$2.19M	0.1%	00.0%	Unchanged	Holders
Q4 2023	53,877	$1.99M	0.1%	+23,811+79.2%	Added	Holders
Q3 2023	30,066	$1.15M	<0.1%	+30,066	New	Holders